News

Allogene Therapeutics Showcases Commitment Through Conferences

Allogene Therapeutics Showcases Commitment Through Conferences

Allogene Therapeutics to Participate in Investor Conferences

Allogene Therapeutics, Inc. (NASDAQ: ALLO), is a pioneering biotechnology company dedicated to developing cutting-edge allogeneic CAR T (AlloCAR T™) products targeting cancer and autoimmune diseases. Recently, the company has announced its involvement in several prominent investor conferences scheduled for the upcoming weeks. These conferences provide critical platforms for Allogene to engage with investors and share its innovative approaches in the biotechnology field.

Upcoming Conferences Overview

Allogene will be featuring its advancements and key insights at four significant conferences:

TD Cowen’s 6th Annual Oncology Innovation Summit

This summit is set to take place on Tuesday, offering vital discussions centered on oncology innovations. The event is crucial for understanding the future of cancer therapy and features leading experts in the field. Allogene will share its vision and insights at 9:30 AM PT/12:30 PM ET.

Jefferies Global Healthcare Conference

Next up is the Jefferies Global Healthcare Conference, happening on June 4. Allogene’s participation is scheduled for the afternoon session at 1:55 PM PT/4:55 PM ET, where they will present their latest developments and strategies aimed at enhancing patient care through innovative therapies.

Goldman Sachs 46th Annual Global Healthcare Conference

This prestigious event will occur on June 10, demonstrating a robust agenda filled with discussions and insights from various healthcare leaders. Allogene will present at 5:00 AM PT/8:00 AM ET, discussing its commitment to providing breakthrough cell therapies.

Oppenheimer Innovators in I&I Summit

Finally, the company will make its mark at the Oppenheimer Innovators in I&I Summit on June 25, presenting at 9:45 AM PT/12:45 PM ET. This summit highlights innovation in immunology and inflammation, areas of significant focus for Allogene.

Webcasting and Accessibility

For those unable to attend in person, Allogene Therapeutics will provide webcasts of the presentations, which will be accessible on their official website. Following each live session, recordings will be available for approximately 30 days, ensuring that all interested parties can catch up on the insights shared by Allogene’s leadership.

Company Overview: Allogene Therapeutics

Based in South San Francisco, Allogene is at the forefront of developing innovative allogeneic chimeric antigen receptor (CAR) T cell therapies for treating cancer and autoimmune diseases. With a team possessing substantial experience in cell therapy, the company is creating a pipeline of off-the-shelf CAR T cell product candidates. Their goal is to make cell therapy available on demand and more accessible to patients, addressing the critical need for timely treatments.

Contact Information

For media and investor inquiries, Christine Cassiano serves as the company’s Executive Vice President, Chief Corporate Affairs & Brand Strategy Officer. Those interested in further information can reach out via email at Christine.Cassiano@allogene.com.

Frequently Asked Questions

What is Allogene Therapeutics known for?

Allogene Therapeutics specializes in developing allogeneic CAR T cell therapies aimed at treating cancer and autoimmune diseases.

How does Allogene's participation in conferences benefit its stakeholders?

Participation in conferences allows Allogene to share insights about its innovative therapies and engage directly with investors, enhancing transparency and collaboration.

Where can I find the presentations from these conferences?

Webcasts of Allogene’s presentations will be available on their website for approximately 30 days following each event.

What is CAR T cell therapy?

CAR T cell therapy involves modifying a patient’s T cells to better recognize and attack cancer cells, providing a personalized approach to treatment.

How can I stay updated on Allogene’s developments?

You can follow Allogene Therapeutics on their official website as well as on social media platforms like X and LinkedIn for the latest updates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Xerox Faces Probes After $130M Profit Forecast Slash

Updated Category News Views 61

When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...

Continue Reading
ATTACK SHARK's X60: A New Era in Gaming Audio

Updated Category News Views 16

Gaming Audio Gets a Power Boost with X60 We're diving headfirst into an era where gaming headsets promise more bells and whistles than ever before. This isn't just some random gadget plopped on the market. ATTACK SHARK's X60 Gaming Headset is strutting in, guns blazing, ready to take on the heavyweights in the competitive gaming world. It's not just about being another...

Continue Reading
DAR Logs Massive 587,000 Service Hours Nationwide

Updated Category News Views 98

A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 171

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
CopperWood Senior Living Revives Historic Campus

Updated Category News Views 55

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Continue Reading
Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Updated Category News Views 70

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

Continue Reading
David Cornue Brings Story Insights to SXSW 2027

Updated Category News Views 89

Crafting Stories with Precision: Cornue's Return In the world where Austin becomes a melting pot of ideas every spring, the return of David Cornue to SXSW casts a familiar, yet electrifying spark. This best-selling author and television whiz is slated to share his story magic at two workshops: one in the Lifestyle track and the other in the Film & TV track. Folks on-site...

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 57

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 106

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
Maison Martell Bridging Artistry: Davido Meets Prince Gyasi

Updated Category News Views 26

Maison Martell Dances to a New Beat The world's oldest cognac house, Maison Martell, is mixing things up in a way that’ll make your typical whiskey-on-the-rocks seem like child’s play. They've snagged Afrobeat heavyweight Davido and renowned visual poet Prince Gyasi to spin a fresh narrative, one where melody and imagery play in harmony. While this ain't your usual...

Continue Reading

Top 5 Most Recently Viewed Articles

StriVectin® Introduces TL Peptight™: Revolutionizing Skincare

Updated Category News Views 131

StriVectin® Launches the TL Peptight™ Face Lift Serum StriVectin®, a prominent leader in skincare innovation, has made a splash in the beauty industry with the launch of its TL Peptight™ Face Lift Serum. This cutting-edge product is set to transform the approach to anti-aging and skin tightening, offering consumers an effective solution without invasive procedures....

Continue Reading
Elliott Investment Management Proposes New Board Candidates

Updated Category News Views 157

Elliott Investment Management Proposes New Board Candidates Elliott Investment Management L.P. has nominated seven highly qualified candidates to serve on the board of directors of Phillips 66. These candidates bring extensive experience in refining, midstream operations, and corporate governance—a move intended to improve accountability and oversight within the...

Continue Reading
Discover the New Hasselblad X2D 100C Earth Explorer Kit

Updated Category News Views 216

Exciting Launch of Hasselblad's X2D 100C Earth Explorer Kit The renowned photography brand Hasselblad has proudly introduced its limited edition X2D 100C Earth Explorer Kit. This extraordinary kit goes beyond just being a camera; it captures the spirit of adventure and exploration, catering to photographers who cherish the stunning beauty of nature. What’s Inside the...

Continue Reading
Could Nvidia Achieve a Trillion Dollar Valuation by 2030?

Updated Category News Views 176

Nvidia's Path to a $10 Trillion Market Cap Nvidia has been a major player in the semiconductor industry, particularly with its GPUs, which have become critical in the realms of gaming, professional visualization, and AI computing. As we move forward, many analysts are beginning to speculate whether Nvidia could reach a remarkable $10 trillion market cap by the end of this...

Continue Reading
China's Charge Toward Sustainable Innovation with NEVs

Updated Category News Views 191

China's Charge Toward Sustainable Innovation with NEVs As the world continues to navigate environmental challenges and climate change, China is stepping up as a formidable player in the field of new energy vehicles (NEVs). This transition has been a cornerstone of China's aspirations to not just be an auto producer but to evolve into a global leader in sustainable...

Continue Reading